Tempus AI Other Share Holders Equity 2023-2024 | TEM

Tempus AI other share holders equity from 2023 to 2024. Other share holders equity can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Tempus AI other share holders equity for the quarter ending September 30, 2024 was $M, a NAN% increase year-over-year.
  • Tempus AI other share holders equity for 2023 was $0B, a NAN% decline from 2022.
  • Tempus AI other share holders equity for 2022 was $0B, a NAN% decline from .
  • Tempus AI other share holders equity for was $0B, a NAN% decline from .
Tempus AI Annual Other Share Holders Equity
(Millions of US $)
2023 $
2022 $
Tempus AI Quarterly Other Share Holders Equity
(Millions of US $)
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30 $0
2023-06-30 $0
2023-03-31 $0
2022-12-31 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $7.994B $0.321B
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.714B 55.57
Hims & Hers Health (HIMS) United States $6.961B 177.00
Inspire Medical Systems (INSP) United States $5.693B 177.56
IRhythm Technologies (IRTC) United States $3.453B 0.00
Privia Health (PRVA) United States $2.701B 225.10
Enovis (ENOV) United States $2.693B 17.94
Azenta (AZTA) United States $2.440B 130.24
Clover Health Investments (CLOV) United States $2.230B 0.00
Omnicell (OMCL) United States $2.070B 67.71
Schrodinger (SDGR) United States $1.819B 0.00
10x Genomics (TXG) United States $1.796B 0.00
Phreesia (PHR) United States $1.669B 0.00
Butterfly Network (BFLY) United States $0.748B 0.00
Standard BioTools (LAB) United States $0.588B 0.00
Talkspace (TALK) United States $0.537B 0.00
Fulgent Genetics (FLGT) United States $0.515B 0.00
TruBridge (TBRG) United States $0.362B 105.43
Nyxoah SA (NYXH) Belgium $0.354B 0.00
Health Catalyst (HCAT) United States $0.343B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.235B 0.00
Pulmonx (LUNG) United States $0.230B 0.00
American Well (AMWL) United States $0.169B 0.00
EUDA Health Holdings (EUDA) Singapore $0.096B 0.00
P3 Health Partners (PIII) United States $0.069B 0.00
CareCloud (CCLD) United States $0.058B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
111 (YI) China $0.047B 0.00
Outset Medical (OM) United States $0.044B 0.00
Zepp Health (ZEPP) China $0.042B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
Zhongchao (ZCMD) China $0.035B 0.00
Movano (MOVE) United States $0.034B 0.00
Bullfrog AI Holdings (BFRG) United States $0.020B 0.00
Streamline Health Solutions (STRM) United States $0.018B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Syra Health (SYRA) United States $0.005B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00